Microarray analysis of ductal carcinoma in situ samples obtained by puncture from surgical resection specimens.
BMC Res Notes
; 14(1): 340, 2021 Aug 30.
Article
in En
| MEDLINE
| ID: mdl-34461994
OBJECTIVE: The incidence of ductal carcinoma in situ (DCIS) is increasing due to more widespread mammographic screening. DCIS, the earliest form of breast cancer, is non-invasive at the time of detection. If DCIS tissues are left undetected or untreated, it can spread to the surrounding breast tissue. Thus, surgical resection is the standard treatment. Understanding the mechanism underlying the non-invasive property of DCIS could lead to more appropriate medical treatments, including nonsurgical options. DATA DESCRIPTION: We conducted a microarray-based genome-wide transcriptome analysis using DCIS specimens obtained by puncture from surgical specimens immediately after surgery.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Carcinoma in Situ
/
Carcinoma, Ductal, Breast
/
Carcinoma, Intraductal, Noninfiltrating
Limits:
Female
/
Humans
Language:
En
Journal:
BMC Res Notes
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: